CynthiaFCaractaMD

PubMed

• 11 citations
  Long-term safety and efficacy of olopatadine-mometasone combination nasal spray in patients with perennial allergic rhinitis.
  Nathan Segall, Bruce M. Prenner, William R. Lumry, Cynthia F. Caracta, Sudeesh K. Tantry> ;Allergy and Asthma Proceedings. 2019 Sep 1
• 15 citations
  Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.
  Frank C. Hampel, Andrew Pedinoff, Robert L. Jacobs, Cynthia F. Caracta, Sudeesh K. Tantry> ;Allergy and Asthma Proceedings. 2019 Jul 3
• 8 citations
  Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
  Lawrence Sher, Gloria Yiu, Anat Sakov, Siyu Liu, Cynthia F. Caracta> ;Allergy and Asthma Proceedings. 2017 Sep 21
• 109 citations
  Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
  Anthony D'Urzo, Stephen I. Rennard, Edward Kerwin, Victor Mergel, Anne Leselbaum, Cynthia Caracta> ;Respiratory Research. 2014 Oct 14
• 49 citations
  Characterisation and impact of reported and unreported exacerbations: results from ATTAIN.
  Paul W. Jones, Rosa Lamarca, Ferran Chuecos, Dave Singh, Alvar Agusti, Eric D. Bateman, Gonzalo de Miquel, Cynthia Caracta, Esther Garcia Gil> ;The European Respiratory Journal. 2014 Jan 1
• 35 citations
  ACCORD COPD II: A Randomized Clinical Trial to Evaluate the 12-Week Efficacy and Safety of Twice-Daily Aclidinium Bromide in Chronic Obstructive Pulmonary Disease Pati...
  Stephen I. Rennard, Paul D. Scanlon, Gary T. Ferguson, Ludmyla Rekeda, Brian Maurer, Esther Garcia Gil, Cynthia Caracta> ;Clinical Drug Investigation. 2013 Oct 2
• 82 citations
  Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from ...
  Jutta Beier, Anne-Marie Kirsten, Robert Mróz, Rosa Segarra, Ferran Chuecos, Cynthia Caracta, Esther Garcia Gil> ;COPD. 2013 Jul 22
• 25 citations
  One-year extension study of ACCORD COPD I: safety and efficacy of two doses of twice-daily aclidinium bromide in patients with COPD.
  Anthony D'Urzo, Edward Kerwin, Stephen I. Rennard, Thomas He, Esther Garcia Gil, Cynthia Caracta> ;COPD. 2013 Jul 22
• 102 citations
  Efficacy and Safety of a 12-week Treatment with Twice-daily Aclidinium Bromide in COPD Patients (ACCORD COPD I)
  Edward Kerwin, Anthony D'Urzo, Arthur F. Gelb, Hassan Lakkis, Esther Garcia Gil, Cynthia Caracta> ;COPD. 2012 Mar 29
• 78 citations
  Efficacy of Aclidinium Bromide 400 μg Twice Daily Compared With Placebo and Tiotropium in Patients With Moderate to Severe COPD
  Rainard Fuhr, Helgo Magnussen, Kristina Sarem, Anna Ribera Llovera, Anne-Marie Kirsten, Meritxell Falques, Cynthia Caracta, Esther Garcia Gil> ;Chest. 2012 Mar 1
• 8 citations
  Mass balance and metabolism of aclidinium bromide following intravenous administration of [¹⁴C]-aclidinium bromide in healthy subjects.
  Stephan Ortiz, Stephen Flach, John Ho, Fanying Li, Cynthia Caracta, Esther Garcia Gil, Josep M. Jansat> ;Biopharmaceutics & Drug Disposition. 2012 Jan 1
• 18 citations
  Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis?
  Carmen M. Stanca, M. Isabel Fiel, Jorge Allina, Cynthia F. Caracta, Joseph A. Odin> ;Seminars in Liver Disease. 2005 Aug 1
• 83 citations
  Gender differences in pulmonary disease.
  Cynthia F Caracta> ;The Mount Sinai Journal of Medicine, New York. 2003 Sep 1
• 25 citations
  Patterns of allelic loss differ in lung adenocarcinomas of smokers and nonsmokers.
  Charles A. Powell, Raphael Bueno, Alain C. Borczuk, Cynthia F Caracta, William G. Richards, David J. Sugarbaker, Jerome S. Brody> ;Lung Cancer. 2003 Jan 1
• Join now to see all